Medtronic Shores Up Tissue Valve Portfolio With ATS Medical Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Medtronic will expand its pericardial tissue heart valve offerings and further strengthen its cardiovascular business through its $370 million acquisition of ATS Medical, announced April 29